Evidence map›Paper›PMID 26221420›Full record

ArticleStandards in genomic sciences2015

Draft genome sequence of Methylibium sp. strain T29, a novel fuel oxygenate-degrading bacterial isolate from Hungary.

Zsolt Szabó, Péter Gyula, Hermina Robotka, Emese Bató, Bence Gálik, Péter Pach, Péter Pekker, Ildikó Papp, Zoltán Bihari

Open access · goldAbstract read
In one paragraph

Article in Standards in genomic sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zsolt Szabó *Bay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Péter Gyula *Bay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Hermina RobotkaBay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Emese BatóBay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Bence GálikBay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Péter PachBay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Péter PekkerMaterials Science Research Group, Hungarian Academy of Sciences-University of Miskolc, Miskolc, Hungary.
Ildikó PappBay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Zoltán BihariBay Zoltán Nonprofit Ltd. for Applied Research, Budapest, Hungary.
Bay Zoltán Foundation for Applied Research · HUHungarian Academy of Sciences · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylibium sp. strain T29 was isolated from a gasoline-contaminated aquifer and proved to have excellent capabilities in degrading some common fuel oxygenates like methyl tert-butyl ether, tert-amyl methyl ether and tert-butyl alcohol along with other organic compounds. Here, we report the draft genome sequence of M. sp. strain T29 together with the description of the genome properties and its annotation. The draft genome consists of 608 contigs with a total size of 4,449,424 bp and an average coverage of 150×. The genome exhibits an average G + C content of 68.7 %, and contains 4754 protein coding and 52 RNA genes, including 48 tRNA genes. 71 % of the protein coding genes could be assigned to COG (Clusters of Orthologous Groups) categories. A formerly unknown circular plasmid designated as pT29A was isolated and sequenced separately and found to be 86,856 bp long.

Indexed as

BetaproteobacteriaBioremediationDraft genomeFuel oxygenatesMethylibium

Identifiers

PMID26221420
PMCPMC4517660
OpenAlexW1483578931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.